Education
About Us
Working with TipRanks
Follow Us
Tarsus Pharmaceuticals (TARS)
NASDAQ:TARS
Tarsus Pharmaceuticals (TARS) Ownership Overview
3.20% Insiders
17.85% Mutual Funds
44.55% Other Institutional Investors
12.51% ETFs
21.88% Public Companies and
Individual Investors
The ownership structure of Tarsus Pharmaceuticals (TARS) stock is a mix of institutional, retail, and individual investors. Approximately 74.92% of the company’s stock is owned by Institutional Investors, 3.20% is owned by Insiders, and 21.88% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 20, 2025 | Bobak R. Azamian President/ceo And Board Chair,director | xxxxxxxxxxxxx | $1163050 |
| Mar 20, 2025 | xxxxxxxxxxxxx | $463766 | |
| Mar 20, 2025 | xxxxxxxxxxxxx | $505856 | |
| Mar 20, 2025 | xxxxxxxxxxxxx | $321323 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $918477 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $6034554 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $10335474 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $22382602 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,989,166 | Institution | 4.83% | 94,465,493 | |
| 1,845,216 | Institution | 4.48% | 87,629,308 | |
| 1,661,756 | Institution | 4.03% | 78,916,792 | |
| 856,562 | Insider | 2.08% | 40,678,129 | |
| 755,106 | Institution | 1.83% | 35,859,984 | |
| 664,863 | Institution | 1.61% | 31,574,344 | |
| 484,800 | Institution | 1.18% | 23,023,152 | |
| 457,189 | Institution | 1.11% | 21,711,906 | |
| 449,122 | Institution | 1.09% | 21,328,804 | |
| 404,411 | Institution | 0.98% | 19,205,478 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,661,756 | Institution | 4.03% | 78,916,792 | |
| 755,106 | Institution | 1.83% | 35,859,984 | |
| 664,863 | Institution | 1.61% | 31,574,344 | |
| 484,800 | Institution | 1.18% | 23,023,152 | |
| 457,189 | Institution | 1.11% | 21,711,906 | |
| 404,411 | Institution | 0.98% | 19,205,478 | |
| 382,765 | Institution | 0.93% | 18,177,510 | |
| 345,851 | Institution | 0.84% | 16,424,464 | |
| 300,000 | Institution | 0.73% | 14,247,000 | |
| 209,981 | Institution | 0.51% | 9,971,998 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,142,308 | Institution | 2.77% | 50,809,860 | |
| 988,441 | Institution | 2.40% | 46,941,063 | |
| 527,805 | Institution | 1.28% | 23,476,766 | |
| 323,983 | Institution | 0.79% | 15,385,953 | |
| 198,294 | Institution | 0.48% | 9,416,982 | |
| 174,973 | Institution | 0.42% | 8,309,468 | |
| 168,157 | Institution | 0.41% | 7,479,623 | |
| 162,473 | Institution | 0.39% | 7,813,327 | |
| 109,068 | Institution | 0.26% | 5,245,080 | |
| 91,132 | Institution | 0.22% | 4,053,551 |
FAQ
Who Owns Tarsus Pharmaceuticals (TARS)?
According to the latest TipRanks data, approximately 44.55% of the company's stock is held by institutional investors, 3.20% is held by insiders, and 21.88% is held by retail investors.
What percentage of Tarsus Pharmaceuticals (TARS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 44.55% of Tarsus Pharmaceuticals (TARS) stock is held by institutional investors.
What percentage of Tarsus Pharmaceuticals (TARS) stock is held by retail investors?
According to the latest TipRanks data, approximately 21.88% of Tarsus Pharmaceuticals (TARS) stock is held by retail investors.
Who owns the most shares of Tarsus Pharmaceuticals (TARS)?
Vanguard owns the most shares of Tarsus Pharmaceuticals (TARS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.